What Causes Low Phosphorus (Hypophosphatemia)
Low serum phosphorus results from three primary mechanisms: inadequate intake/decreased intestinal absorption, intracellular redistribution, and increased phosphate losses (renal or dialytic). 1
Primary Pathophysiological Mechanisms
Hypophosphatemia develops through disruption of the normal phosphate balance between uptake and excretion. The three main pathways are:
1. Inadequate Intake or Decreased Intestinal Absorption
- Malnutrition - chronic caloric deprivation
- Malabsorptive disorders - bariatric surgery, inflammatory bowel disease, celiac disease 2
- Vitamin D deficiency - reduces intestinal phosphate absorption 3
- Phosphate-binding antacids - chelate dietary phosphate 4
2. Intracellular Redistribution (Transcellular Shift)
- Refeeding syndrome - the most critical cause when nutrition is reintroduced after deprivation, especially when carbohydrate-heavy 1
- Intravenous glucose/dextrose administration - drives phosphate into cells for ATP production 4
- Insulin therapy - particularly intensive insulin in diabetic ketoacidosis 4, 5
- Respiratory alkalosis - shifts phosphate intracellularly 6, 4
3. Increased Phosphate Losses
Renal losses:
- Kidney replacement therapy (KRT) - especially intensive/prolonged continuous renal replacement therapy (CRRT), with prevalence reaching 60-80% in ICU patients 1
- Primary hyperparathyroidism - increases renal phosphate excretion 3
- Genetic disorders - X-linked hypophosphatemia (XLH) due to PHEX mutations is the most common genetic cause with overt skeletal phenotype 7, 8
- Drug-induced FGF23 elevation - ferric carboxymaltose (FCM) causes severe hyperphosphaturic hypophosphatemia in 47-75% of patients through iFGF23 surge 2
- Diuretics - increase urinary phosphate wasting 6, 4
- Fanconi syndrome and proximal tubulopathies - multiple causes including cystinosis, drug toxicity 7
Context-Specific Causes
In Hospitalized Patients
The most common causes in hospitalized patients are multifactorial 6:
- Respiratory alkalosis (48.3% of cases)
- Malnutrition
- Medications - diuretics, corticosteroids, proton pump inhibitors
- Diabetes mellitus
- Secondary hyperparathyroidism
- Intravenous dextrose - considered primary cause in 45% of hospitalized hypophosphatemia cases 4
Critical pitfall: 75.6% of hospitalized patients with hypophosphatemia have more than one contributing cause 6. Look for concurrent electrolyte disorders: hypocalcemia (40.9%), hyponatremia (38.6%), hypomagnesemia (23.9%), hypokalemia (22.7%) 6.
In ICU/Critically Ill Patients
- Initiation of KRT - represents a major risk factor, especially with phosphate-free dialysate solutions 1
- Refeeding syndrome - when medical nutrition is started, particularly carbohydrate-predominant 1
- Intensive dialysis strategies - hypophosphatemia prevalence can reach 80% 1
Iatrogenic Causes Requiring Special Attention
Ferric carboxymaltose (FCM) administration deserves particular emphasis as it causes severe, prolonged hypophosphatemia lasting up to 6 months 2. FCM should be avoided in patients with recurrent blood loss (abnormal uterine bleeding, hereditary hemorrhagic telangiectasia, GI bleeding) or malabsorptive disorders requiring repeat infusions, as it can lead to osteomalacia and fractures 2.
The mechanism involves FCM triggering a sharp rise in intact FGF23, causing renal phosphate wasting, calcitriol deficiency, and secondary hyperparathyroidism 2.
Genetic Causes (Chronic Hypophosphatemia)
When acquired causes are excluded in patients with persistent hypophosphatemia:
- X-linked hypophosphatemia (XLH) - PHEX gene mutations, most common genetic cause 7, 8
- Autosomal dominant/recessive hypophosphatemic rickets - FGF23, SLC34A3, SLC34A1 mutations 7
- Hereditary hypophosphatemic rickets with hypercalciuria - SLC34A3 mutations 7
Genetic causes should be considered in both children and adults with unexplained hypophosphatemia, particularly when family history or skeletal abnormalities are present 8.
Clinical Significance
Hypophosphatemia severity is classified as:
- Mild: <2.5 mg/dL (0.81 mmol/L)
- Moderate: 1.5-2.0 mg/dL (0.32-0.65 mmol/L)
- Severe: <1.5 mg/dL (0.32 mmol/L)
- Life-threatening: <1.0 mg/dL 2
The association with worsening respiratory failure, prolonged mechanical ventilation weaning, cardiac arrhythmias, and increased mortality makes identifying the cause critical in hospitalized patients 1. Mortality in hypophosphatemic hospitalized patients is markedly elevated (15.9% vs 4.26% overall) 6.